Thermo Fisher Buying BRAHMS
Thermo Fisher Scientific Inc. (NYSE: TMO) has agreed to acquire BRAHMS AG, a Germany-based provider of provider of specialty in-vitro diagnostic tests, for €330 million. BRAHMS is owned by HBM BioVentures and company management.
3 September 2009•3 mins read
